Additional information
Yellow Powder
73319-30-9
ACI-221104
1-[3a,17ß-dihydroxy-2ß-(piperidin-1-yl)-5a-androstan-16ß-yl]-1-methylpiperidin-1-ium bromide
1-[(2ß,3a,5a,16ß,17ß)-3,17-Dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium bromide
258.0-259.3°C (dec.)
C30H53BrN2O2
552.33
Ambient
2-8°C
Vecuronium Bromide USP Related Compound C
Neuromuscular blocking agent





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)